Oligotide anti-ischemic effect is related to in vitro inhibition of leukocyte-endothelial cell adhesion.
Pellegatta
F
F
Istituto di Pathologia Generale, Università di Milano, Italy.
Ferrero
E
E
Marni
A
A
Chierchia
S
S
Forti
D
D
Ferrero
M E
ME
D016475:3T3 Cells; D000818:Animals; D002448:Cell Adhesion / Q000187:drug effects*; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D066298:In Vitro Techniques; D018799:Intercellular Adhesion Molecule-1 / Q000096:biosynthesis / Q000502:physiology*; D007511:Ischemia; D007962:Leukocytes / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009838:Oligodeoxyribonucleotides / Q000493:pharmacokinetics* / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000096:biosynthesis; D018709:Statistics, Nonparametric; D014162:Transfection; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D014471:Umbilical Veins
D009838:Oligodeoxyribonucleotides; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D018799:Intercellular Adhesion Molecule-1; C099595:oligotide; D009240:N-Formylmethionine Leucyl-Phenylalanine